Parametrica Management Ltd
- SEC CIK
- 0001535110
- Latest filing
- Aug 12, 2026
ALNY holding history
Alnylam Pharmaceuticals, Inc. in every 13F filed by Parametrica Management Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −3,221−100.0% | Sold out | Holders |
| Q3 2023 | 3,221 | $570.4K | 1.0% | −7,025−68.6% | Reduced | Holders |
| Q2 2023 | 10,246 | $1.95M | 3.7% | +4,293+72.1% | Added | Holders |
| Q1 2023 | 5,953 | $1.19M | 2.2% | −3,547−37.3% | Reduced | Holders |
| Q4 2022 | 9,500 | $2.26M | 4.6% | −4,339−31.4% | Reduced | Holders |
| Q3 2022 | 13,839 | $2.77M | 5.7% | +13,839 | New | Holders |